What's New in Opioids, Mental Health, HIV, and STIs (Day 2 of 2)
Join Us for a Virtual Conference provided in collaboration by:
The STD/HIV Prevention Training Center, MidAtlantic AETC, The Danya Institute-Central East Addiction Technology Transfer Center, National Family Planning and Reproductive Health Association, Rutgers Global Tuberculosis Institute, and DC Area Health and Education Centers-Georgetown University.
Important note: To receive continuing education credit, you must attend both days in their entirety (September 11th - Day 1, September 25th - Day 2).
This conference will focus on the integration efforts that support a collaborative healthcare approach. Current medical updates in services for STIs, HIV, TB, hepatitis, family planning and addictions will be discussed.
After completing this conference, the learner should be able to:
- State current practice in the care and treatment of STIs, HIV, TB, and hepatitis
- Explain how to screen clients for substance abuse issues
- Identify Population at risk for HIV/STIs/Mental Health and Substance Abuse
- Demonstrate effective team skills by sharing information effectively, listening and responding to feedback from others, and using simple communication
VIRTUAL UPDATE AGENDA - Friday September 25th, 2020 - Day 2
Reminders, Short Introduction
Speaker: Jeanne Hoover, STD/HIV PTC at Johns Hopkins University
Providing Culturally Competent Care
Speaker: Deborah Dunn, Family Practice PA-C
Addiction, Treatment, Recovery in Pregnancy and Postpartum
Speaker: Mishka Terplan, MD, MPH
Q&A, Evaluation, Adjournment
This course has been designed for physicians, physician assistants, clinicians, nurses, nurse practitioners, counselors, social workers, educators, case managers, and intervention specialists working in addictions, TB/STI/HIV agencies and other programs.
Important note: To receive continuing education credit, you must attend both days.
To register for Day 1: Please visit: https://www.maaetc.org/events/view/15783
Please contact the MidAtlantic AETC at firstname.lastname@example.org with questions or concerns.
CME activities with Joint Providers: This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Centers for Disease Control and Prevention and STD/HIV Prevention Training Center at Johns Hopkins. The Centers for Disease Control and Prevention is accredited by the (ACCME®) to provide medical education for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity. The Centers for Disease Control and Prevention designates this live activity for a maximum of 6.25 AMA PRA Category 1 Credits™.
CNE: The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center's Commission on Accreditation. This activity provides 6.2 contact hours.
CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer .6 CEU's for this program.
CECH: Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES®) and/or Master Certified Health Education Specialists (MCHES®) to receive up to 6.5 total Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 0. CDC provider number 98614.
For Certified Public Health Professionals (CPH): The Centers for Disease Control and Prevention is a pre-approved provider of Certified in Public Health (CPH) recertification credits and is authorized to offer 6.5 CPH recertification credits for this program.
Central East ATTC is a NAADAC approved continuing education provider and has approved up to 5.25 contact hours for this combined event.
A variety of the listed populations will be discussed at this event.
- Gay, lesbian, bisexual, transgender, or other gender
Day 1 Registration:
12-SCWC4196 What's New Update DC:
A variety of the listed topics will be discussed at this event.
- Harm Reduction/Safe Injection
- HIV Transmission Risk Assessment
- Medication-assisted therapy for substance use disorders (i.e. buprenorphine, methadone, and/or naltrexone)
- Sexually transmitted infections
- Substance use disorders
- Opioid use disorder
- Cultural competence